Nuclear Medicine Equipment Market Report 2025

This nuclear medicine equipment market report delivers an in-depth analysis of the market’s key characteristics, including size, growth potential, and segmentation. It provides a detailed breakdown of the market across major regions and leading countries, highlighting historical data and future growth projections. The report also examines the competitive landscape, market share insights, emerging trends, and strategic developments shaping the market.

The nuclear medicine equipment market size has grown strongly in recent years. It will grow from $2.66 billion in 2024 to $2.81 billion in 2025 at a compound annual growth rate (CAGR) of 5.8%. The growth in the historic period can be attributed to increasing demand for early disease detection, growth in the aging population, growth in healthcare infrastructure, rising funding for research and development, and rising demand for functional imaging.

The nuclear medicine equipment market size is expected to see strong growth in the next few years. It will grow to $3.49 billion in 2029 at a compound annual growth rate (CAGR) of 5.5%. The growth in the forecast period can be attributed to rising cancer incidences, increasing cost of nuclear imaging systems, increasing focus on personalized medicine, growing adoption of hybrid imaging systems, and rising demand for alzheimer's and parkinson's disease treatment and diagnostics. Major trends in the forecast period include technological advancements, integration of AI, hybrid imaging systems, telemedicine, and miniaturized devices.

The rising incidence of cardiac conditions is expected to drive the growth of the nuclear medicine equipment market. Cardiac ailments, encompassing a variety of diseases affecting the heart and blood vessels, impact heart function, structure, and blood flow. The increase in these conditions is mainly due to factors such as aging populations, lifestyle choices (such as poor diet and lack of exercise), environmental exposures, and advancements in diagnostic technologies that improve detection. Nuclear medicine equipment plays a crucial role in managing cardiac ailments by providing detailed imaging and diagnostic information, which aids in early detection, accurate staging, and effective monitoring of these diseases. For example, the British Heart Foundation reported in January 2024 that approximately 7.6 million people in the UK are affected by heart and circulatory diseases. These conditions account for about 27% of all deaths in the UK, leading to over 170,000 deaths annually, or approximately 480 deaths each day. Thus, the increasing prevalence of cardiac ailments is fueling the growth of the nuclear medicine equipment market.

Key players in the nuclear medicine equipment market are focusing on developing advanced technologies, such as PET/CT scanners, to deliver detailed, functional images of the body’s metabolic processes. A PET/CT scanner combines positron emission tomography (PET) and computed tomography (CT) into one device, offering both functional and anatomical imaging in a single session for more accurate condition detection and diagnosis. For instance, Siemens Healthineers, a Germany-based healthcare company, introduced the Biograph Trinion PET/CT scanner in June 2024. This scanner features a unique, scalable axial field-of-view design that allows for on-site technological upgrades without the need for costly room renovations or workflow disruptions. It uses a lutetium oxyorthosilicate (LSO) crystal detector for high spatial resolution and ultrafast time-of-flight performance of 239 picoseconds, which enhances small lesion detectability and provides sensitivity up to 128 cps/kBq. This results in quicker scans with lower patient radiation doses. Additionally, the Biograph Trinion includes a new air-cooled digital detector, making installation simpler compared to traditional water-cooled systems.

In November 2023, Mirion Technologies Inc., a US-based company specializing in radiation detection, measurement, and protection equipment, acquired ec2 Software Solutions. This acquisition aims to enhance Mirion Technologies’ nuclear medicine and molecular imaging portfolio by integrating ec2’s advanced software solutions, thereby improving its capabilities in providing comprehensive and innovative imaging and data management solutions. Ec² Software Solutions is a US-based provider of nuclear medicine equipment.

Major companies operating in the nuclear medicine equipment market are Fujifilm Holdings Corporation, Koninklijke Philips N.V., General Electric Company, Shimadzu Corporation, Mallinckrodt Pharmaceuticals, Curium Pharma, Bartec Technologies Ltd., Cardinal Health Inc., Canon Medical Systems Corporation, Digirad Corporation, TTG Imaging Solutions, Biodex Medical Systems Inc., Spectrum Dynamics Medical, Mediso Ltd., Cyclopharm Limited, Siemens Healthineers AG, Capintec Inc., Laboratorios Bacon S.A., Von Gahlen, Toshiba Medical Systems Corporation, Elysia-Raytest, MR Solutions Ltd., DDD-Diagnostic A/S, MILabs B.V.

North America was the largest region in the nuclear medicine equipment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the nuclear medicine equipment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the nuclear medicine equipment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Nuclear medicine equipment consists of specialized devices used to diagnose and treat diseases through the use of radioactive substances. These devices either capture detailed images of organs and tissues or deliver targeted radiation therapy. They are essential for early diagnosis, treatment planning, and monitoring of conditions, particularly cancers and cardiovascular disorders.

The main products in nuclear medicine equipment include single photon emission computed tomography (SPECT), hybrid positron emission tomography (PET), and planar scintigraphy. SPECT is an imaging technique that utilizes gamma rays to produce detailed, three-dimensional images of the body’s internal structures. These technologies are used in various medical fields such as oncology, cardiology, and neurology, and are employed by hospitals, imaging centers, academic and research institutions, and other healthcare facilities.

The nuclear medicine equipment market research report is one of a series of new reports that provides nuclear medicine equipment market statistics, including nuclear medicine equipment industry global market size, regional shares, competitors with a nuclear medicine equipment market share, detailed nuclear medicine equipment market segments, market trends and opportunities, and any further data you may need to thrive in the nuclear medicine equipment industry. This nuclear medicine equipment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The nuclear medicine equipment market consists of sales of gamma cameras, dose calibrators, radiation detectors and related products. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.